SIMULTANEOUS DETERMINATION OF RUFLOXACIN, FENBUFEN AND FELBINAC IN HUMAN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY

Citation
G. Carlucci et al., SIMULTANEOUS DETERMINATION OF RUFLOXACIN, FENBUFEN AND FELBINAC IN HUMAN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 682(2), 1996, pp. 315-319
Citations number
10
Categorie Soggetti
Chemistry Analytical","Biochemical Research Methods
Journal title
Journal of chromatography B. Biomedical applications
ISSN journal
15726495 → ACNP
Volume
682
Issue
2
Year of publication
1996
Pages
315 - 319
Database
ISI
SICI code
Abstract
A simple, specific and sensitive high-performance liquid chromatograph ic method has been developed for the simultaneous determination of ruf loxacin, fenbufen and felbinac in human plasma. Plasma, spiked with in ternal standard, was vortex-mixed for 1 min with a mixture of dichloro methane-diethyl ether (80:20, v/v). The evaporated extract was dissolv ed in 0.02 M NaOH. Drugs were resolved at room temperature on a 5 mu m Zorbax SAX column (250X4.6 mm I.D.) equipped with a 20X4.6 mm anion-e xchange Vydac AXGU (10 mu m particle size) precolumn. The mobile phase consisted of acetonitrile and phosphate buffer (pH 7.0): delivered at a flow-rate of 1.2 ml/min. Detection was made at 280 nm. 2-[4-(2'-Fur oyl)phenyl]propionic acid was used as internal standard. The calibrati on curve was linear from 0.2 to 10 mu g/ml for rufloxacin, from 0.5 to 30 mu g/ml for fenbufen and from 0.2 to 10 mu g/ml for felbinac, resp ectively. The detection limit was 0.1 mu g/ml for rufloxacin, 0.3 mu g /ml for fenbufen and 0.1 mu g/ml for felbinac, respectively.